Award
NIH Reporter #4R01CA285684-03
A novel role for EZH2 in PARP regulation and PARPi-resistance in prostate cancer
Recipient
Northwestern University, Chicago, IL
Award Amount
$1,701,594.00
Ceiling
$1,701,594.00
Awarded
June 30, 2026
Identifier
4R01CA285684-03
The award supports research on the role of EZH2 in prostate cancer and resistance to PARP inhibitors, aiming to develop effective treatments for metastatic prostate cancer.
Description
This project aims to elucidate the role of EZH2 in prostate cancer progression and resistance to PARP inhibitors, with potential implications for developing targeted therapies.